Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 2)

Published 2021-05-06

Recommendations

1:42:21

Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 3)
01:33

Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? | Researching FDA
01:27

Dr. Matthew Hahn on Treating OUD with Medication
1:01:25

Osteoporosis: A Perspective for 2024
3:01:55

Facilitating Generic Drug Product Development through Product-Specific Guidances
1:23:58

Statistical Considerations for Premarketing Risk Assessment
01:48

The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5
01:06

Prescribe with Confidence: Dr. Califf introduces FDA’s MOUD campaign for health care professionals
00:26

Waterproof Sunscreen? Sun Safety Tips from Episode 5 of FDA In Your Day | Full Video on Channel
6:04:12

REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2)
00:31

Dr. Matthew Hahn on the Importance of Destigmatizing OUD Treatment
2:26:13

Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval
6:01:40

May 22, 2024 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
5:48:02

REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 1 of 2)
00:31

An MOUD Success Story from Dr. Matthew Hahn
7:42:03

REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2)
7:13:56

REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 2 of 2)
6:52:20

REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 2 of 2)
7:33:16

May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting
7:35:04

REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2)

Similar videos